Iatros Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-06-2024
- Paid Up Capital ₹ 5.05 M
as on 24-06-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.39 Cr
as on 24-06-2024
- Revenue -22.92%
(FY 2021)
- Profit -54.73%
(FY 2021)
- Ebitda -34.80%
(FY 2021)
- Net Worth 1.13%
(FY 2021)
- Total Assets -2.95%
(FY 2021)
About Iatros Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.05 M.
The company has closed loans amounting to ₹1.39 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Preeti Shah, Ajit Shah, Anilkumar Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232MH1989PTC051161
- Company No.
051161
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 1989
- Date of AGM
12 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Iatros Pharmaceutical Pvt Ltd offer?
Iatros Pharmaceutical Pvt Ltd offers a wide range of products and services, including Veterinary Medicines, Anthelmintics, Pharmaceutical Capsules, Softgel Capsules, Pain Killers, Forte Tablets, Mineral Supplement, Calcium Supplements, Anti Inflammatory Drugs, Nimesulide Tablet.
Who are the key members and board of directors at Iatros Pharmaceutical?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preeti Shah  | Director | 28-Feb-2022 | Current |
| Ajit Shah | Director | 28-Mar-1989 | Current |
| Anilkumar Shah | Director | 28-Mar-1989 | Current |
| Pravin Shah | Director | 28-Mar-1989 | Current |
| Vaibhav Shah | Director | 07-Jun-2019 | Current |
Financial Performance of Iatros Pharmaceutical.
Iatros Pharmaceutical Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 22.92% decrease. The company also saw a substantial fall in profitability, with a 54.73% decrease in profit. The company's net worth moved up by a moderate rise of 1.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iatros Pharmaceutical?
In 2021, Iatros Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Iatro Pharma And Biotech LimitedActive 19 years 5 monthsAjit Shah and Anilkumar Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Karad Urban Co-Operative Bank Ltd. Creation Date: 21 Mar 2009 | ₹2.50 M | Satisfied |
The Karad Urban Co-Operative Bank Ltd. Creation Date: 02 Feb 2009 | ₹7.50 M | Satisfied |
Shri Parshwanath Coop. Bank Ltd Creation Date: 07 Jun 2004 | ₹3.10 M | Satisfied |
How Many Employees Work at Iatros Pharmaceutical?
Unlock and access historical data on people associated with Iatros Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iatros Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iatros Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
